IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors. FDA decision on ...

Commissions do not affect our editors' opinions or evaluations. If you’ve been diagnosed with cancer and do not already have a policy in place, you will find your life insurance options much mor ...

Kidney failure occurs when your kidneys lose the ability to filter waste from your blood sufficiently. It may not cause symptoms in the early stages. Your kidneys filter your blood and remove ...

Although most people have two kidneys, only one kidney can function just as well as two. You may need to take some precautions to avoid injury to your kidney, though, and see a doctor for regular ...

Routine gonadal and sexual health assessments are necessary in this population. Erectile dysfunction (ED) and testosterone deficiency (TD) are more common among men with testicular cancer, a new ...

The U.S. Food and Drug Administration (FDA) has announced that Boston Scientific Corporation is updating use instructions for POLARx and POLARx FIT Cryoablation Balloon Catheters, emphasizing the risk ...

XSense™ system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure CAESAREA, Israel, Jan. 3 ...

There are several types of kidney (renal) cancer. Each type is potentially curable if it’s found and treated early before the cancer has a chance to spread. Kidney cancer is categorized in stages from ...

Kidney cancer happens when cells in one or both kidneys start to grow out of control. Eventually, the cells become a mass called a tumor. As the cancer progresses, it can spread to other parts of the ...

Caesarea, Israel-based IceCure designed it to work as part of its XSense cryoablation system ... Targets include fibroadenomas, kidney tissue, liver metastases, tumors, skin lesions and warts.

Patterns of "speckles" in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to different treatment options, according to research.